UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000054161 |
|---|---|
| Receipt number | R000061850 |
| Scientific Title | Which is better in opioid titration for cancer pain, oral or injection? A systematice review. |
| Date of disclosure of the study information | 2024/04/16 |
| Last modified on | 2024/10/29 17:02:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Which is better in opioid titration for cancer pain, oral or injection? A systematice review.
Acronym
Which is better in opioid titration for cancer pain, oral or injection? A systematice review.
Scientific Title
Which is better in opioid titration for cancer pain, oral or injection? A systematice review.
Scientific Title:Acronym
Which is better in opioid titration for cancer pain, oral or injection? A systematice review.
Region
| Japan | Asia(except Japan) | North America |
| South America | Australia | Europe |
| Africa |
Condition
Condition
cancer pain
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To assess which way of opoid titration is better for alliviating cancer pain, oral or injection, by systematic literature search.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Duration until achievement of alliviating cancer pain
Key secondary outcomes
adverse effects, QOL
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Adult cancer patients who receive or begin to receive opioids for relieving cancer pain.
Key exclusion criteria
Patients whose pain mainly result from cancer treatment or associated diseases other than cancer.
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | Natsuki |
| Middle name | |
| Last name | Nakagawa |
Organization
The university of Tokyo hospital
Division name
Department of respiratory medicine
Zip code
1138655
Address
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
TEL
0338155411
nnakagawa-tky@umin.ac.jp
Public contact
Name of contact person
| 1st name | Natsuk |
| Middle name | |
| Last name | Nakagawa |
Organization
The University of Tokyo Hospital
Division name
Department of pulmonary medicine
Zip code
1138655
Address
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
TEL
0338155411
Homepage URL
nnakagawautmedsle@yahoo.co.jp
Sponsor or person
Institute
The university of Tokyo
Institute
Department
Personal name
Funding Source
Organization
Not applicable
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Not applicable
Address
Not applicable
Tel
0338155411
nnakagawa-tky@umin.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 04 | Month | 16 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2024 | Year | 04 | Month | 16 | Day |
Date of IRB
| 2024 | Year | 04 | Month | 16 | Day |
Anticipated trial start date
| 2024 | Year | 04 | Month | 16 | Day |
Last follow-up date
| 2024 | Year | 04 | Month | 16 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Literature search has been analyzed, and publication preparation is underway
Management information
Registered date
| 2024 | Year | 04 | Month | 16 | Day |
Last modified on
| 2024 | Year | 10 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061850
